Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery.

Lee H, Lytton-Jean AK, Chen Y, Love KT, Park AI, Karagiannis ED, Sehgal A, Querbes W, Zurenko CS, Jayaraman M, Peng CG, Charisse K, Borodovsky A, Manoharan M, Donahoe JS, Truelove J, Nahrendorf M, Langer R, Anderson DG.

Nat Nanotechnol. 2012 Jun 3;7(6):389-93. doi: 10.1038/nnano.2012.73.

PMID:
22659608
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.

Dong DW, Xiang B, Gao W, Yang ZZ, Li JQ, Qi XR.

Biomaterials. 2013 Jul;34(20):4849-59. doi: 10.1016/j.biomaterials.2013.03.018. Epub 2013 Mar 27.

PMID:
23541420
[PubMed - indexed for MEDLINE]
3.

The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.

Patil YB, Swaminathan SK, Sadhukha T, Ma L, Panyam J.

Biomaterials. 2010 Jan;31(2):358-65. doi: 10.1016/j.biomaterials.2009.09.048. Epub 2009 Oct 1.

PMID:
19800114
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Gene delivery: Designer DNA give RNAi more spine.

Bhatia D, Chakraborty S, Krishnan Y.

Nat Nanotechnol. 2012 Jun 3;7(6):344-6. doi: 10.1038/nnano.2012.87. No abstract available.

PMID:
22659610
[PubMed - indexed for MEDLINE]
5.

Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.

Yoshizawa T, Hattori Y, Hakoshima M, Koga K, Maitani Y.

Eur J Pharm Biopharm. 2008 Nov;70(3):718-25. doi: 10.1016/j.ejpb.2008.06.026. Epub 2008 Jul 4.

PMID:
18647651
[PubMed - indexed for MEDLINE]
6.

N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver.

Wang HX, Xiong MH, Wang YC, Zhu J, Wang J.

J Control Release. 2013 Mar 10;166(2):106-14. doi: 10.1016/j.jconrel.2012.12.017. Epub 2012 Dec 20.

PMID:
23266452
[PubMed - indexed for MEDLINE]
7.

Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.

Lin D, Cheng Q, Jiang Q, Huang Y, Yang Z, Han S, Zhao Y, Guo S, Liang Z, Dong A.

Nanoscale. 2013 May 21;5(10):4291-301. doi: 10.1039/c3nr00294b.

PMID:
23552843
[PubMed - indexed for MEDLINE]
8.

Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA.

Wang SL, Yao HH, Guo LL, Dong L, Li SG, Gu YP, Qin ZH.

Cancer Genet Cytogenet. 2009 Apr 1;190(1):8-14. doi: 10.1016/j.cancergencyto.2008.10.013.

PMID:
19264227
[PubMed - indexed for MEDLINE]
9.

Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I.

Kim SI, Shin D, Choi TH, Lee JC, Cheon GJ, Kim KY, Park M, Kim M.

Mol Ther. 2007 Jun;15(6):1145-52. Epub 2007 Apr 17.

PMID:
17440441
[PubMed - indexed for MEDLINE]
10.

Self-assembled and nanostructured siRNA delivery systems.

Jeong JH, Park TG, Kim SH.

Pharm Res. 2011 Sep;28(9):2072-85. doi: 10.1007/s11095-011-0412-y. Epub 2011 Mar 18. Review.

PMID:
21424157
[PubMed - indexed for MEDLINE]
11.

Targeting of nanoparticles: folate receptor.

Kularatne SA, Low PS.

Methods Mol Biol. 2010;624:249-65. doi: 10.1007/978-1-60761-609-2_17.

PMID:
20217601
[PubMed - indexed for MEDLINE]
12.

Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.

Beh CW, Seow WY, Wang Y, Zhang Y, Ong ZY, Ee PL, Yang YY.

Biomacromolecules. 2009 Jan 12;10(1):41-8. doi: 10.1021/bm801109g.

PMID:
19072631
[PubMed - indexed for MEDLINE]
13.

Nanoparticle-based delivery system for application of siRNA in vivo.

Wang Y, Li Z, Han Y, Liang LH, Ji A.

Curr Drug Metab. 2010 Feb;11(2):182-96. Review.

PMID:
20359287
[PubMed - indexed for MEDLINE]
14.

Targeted delivery of siRNA-generating DNA nanocassettes using multifunctional nanoparticles.

Cho YS, Lee GY, Sajja HK, Qian W, Cao Z, He W, Karna P, Chen X, Mao H, Wang YA, Yang L.

Small. 2013 Jun 10;9(11):1964-73. doi: 10.1002/smll.201201973. Epub 2013 Jan 6.

PMID:
23292656
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.

Mitra M, Kandalam M, Rangasamy J, Shankar B, Maheswari UK, Swaminathan S, Krishnakumar S.

Mol Vis. 2013 May 6;19:1029-38. Print 2013.

PMID:
23687439
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Therapeutic siRNA: principles, challenges, and strategies.

Gavrilov K, Saltzman WM.

Yale J Biol Med. 2012 Jun;85(2):187-200. Epub 2012 Jun 25. Review.

PMID:
22737048
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Targeted gene silencing by small interfering RNA-based knock-down technology.

Zhang J, Hua ZC.

Curr Pharm Biotechnol. 2004 Feb;5(1):1-7. Review.

PMID:
14965205
[PubMed - indexed for MEDLINE]
18.

Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies.

Fernandes JC, Qiu X, Winnik FM, Benderdour M, Zhang X, Dai K, Shi Q.

Int J Nanomedicine. 2012;7:5833-45. doi: 10.2147/IJN.S35567. Epub 2012 Nov 23.

PMID:
23209368
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Nanoformulation of siRNA silencing Bcl-2 gene and its implication in cancer therapy.

Jagani HV, Josyula VR, Hariharapura RC, Palanimuthu VR, Gang SS.

Arzneimittelforschung. 2011;61(10):577-86. doi: 10.1055/s-0031-1300556.

PMID:
22164966
[PubMed - indexed for MEDLINE]
20.

Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.

Cheng CJ, Saltzman WM.

Biomaterials. 2011 Sep;32(26):6194-203. doi: 10.1016/j.biomaterials.2011.04.053. Epub 2011 Jun 12.

PMID:
21664689
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk